Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Studies in a murine B16 melanoma model show that persistent antigen at vaccination sites induces CD8+ T cell sequestration, dysfunction and deletion


ABSTRACT: To understand why cancer vaccine-induced T cells often fail to eradicate tumors, we studied immune responses in mice vaccinated with gp100 peptide emulsified in incomplete Freund's adjuvant (IFA), commonly used in clinical cancer vaccine trials. After gp100 peptide/IFA vaccination, tumor-specific CD8+ T cells (adoptively transferred from gp100-specific TCR-transgenic pmel-1 mice) accumulated not in tumors but at the persisting, antigen-rich vaccination site. Once there, primed T cells became dysfunctional and underwent antigen-driven, IFN-γ and FasL-mediated apoptosis, resulting in systemic hyporesponsiveness to subsequent vaccination. Provision of anti-CD40 antibody, TLR7 agonist and interleukin-2 (covax) reduced T cell apoptosis but did not prevent vaccination site sequestration. A non-persisting vaccine formulation shifted T cell localization towards tumors, inducing superior anti-tumor activity. Short-lived formulation also reduced systemic T cell dysfunction and promoted memory formation, as shown by gene expression profiling and other measures. Persisting peptide/IFA vaccine depots, currently used to vaccinate cancer patients, can induce specific T cell sequestration at vaccination sites followed by dysfunction and deletion; short-lived depot formulations may overcome these limitations and result in greater therapeutic efficacy of peptide-based cancer vaccines. To study the fate of melanoma-specific CD8+ T cells after peptide vaccination, we tracked T cell receptor-transgenic pmel-1 T cells in mice vaccinated with heteroclitic gp100_25-33 peptide emulsified in IFA. Splenic pmel-1 CD8+ T cells were purified at 6 and 21 days after vaccination with either gp100/IFA/covax or gp100/saline/covax, and then their total RNA was extracted and used for comparison by gene expression profiling.

ORGANISM(S): Mus musculus

SUBMITTER: Wencai Ma 

PROVIDER: E-GEOD-43929 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2013-03-02 | GSE43929 | GEO
2017-08-31 | GSE94538 | GEO
2016-06-14 | E-GEOD-79475 | biostudies-arrayexpress
2012-12-01 | GSE30564 | GEO
2012-12-01 | E-GEOD-30564 | biostudies-arrayexpress
2023-08-01 | E-MTAB-13053 | biostudies-arrayexpress
2010-10-19 | E-GEOD-22443 | biostudies-arrayexpress
2012-04-22 | E-GEOD-29164 | biostudies-arrayexpress
2012-06-14 | E-GEOD-35628 | biostudies-arrayexpress
2014-08-25 | E-GEOD-57304 | biostudies-arrayexpress